These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 20575052

  • 1. Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen.
    González-Mira E, Nikolić S, García ML, Egea MA, Souto EB, Calpena AC.
    J Pharm Sci; 2011 Jan; 100(1):242-51. PubMed ID: 20575052
    [Abstract] [Full Text] [Related]

  • 2. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.
    Gonzalez-Mira E, Egea MA, Garcia ML, Souto EB.
    Colloids Surf B Biointerfaces; 2010 Dec 01; 81(2):412-21. PubMed ID: 20719479
    [Abstract] [Full Text] [Related]

  • 3. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation.
    Han F, Yin R, Che X, Yuan J, Cui Y, Yin H, Li S.
    Int J Pharm; 2012 Dec 15; 439(1-2):349-57. PubMed ID: 22989987
    [Abstract] [Full Text] [Related]

  • 4. Improved and safe transcorneal delivery of flurbiprofen by NLC and NLC-based hydrogels.
    Gonzalez-Mira E, Nikolić S, Calpena AC, Egea MA, Souto EB, García ML.
    J Pharm Sci; 2012 Feb 15; 101(2):707-25. PubMed ID: 22012873
    [Abstract] [Full Text] [Related]

  • 5. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
    Gonzalez-Mira E, Egea MA, Souto EB, Calpena AC, García ML.
    Nanotechnology; 2011 Jan 28; 22(4):045101. PubMed ID: 21169662
    [Abstract] [Full Text] [Related]

  • 6. Nanostructured lipid carriers-based flurbiprofen gel after topical administration: acute skin irritation, pharmacodynamics, and percutaneous absorption mechanism.
    Song A, Su Z, Li S, Han F.
    Drug Dev Ind Pharm; 2015 Jan 28; 41(9):1488-92. PubMed ID: 25231972
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Investigation of nanostructured lipid carriers for transdermal delivery of flurbiprofen.
    Han F, Li S, Yin R, Shi X, Jia Q.
    Drug Dev Ind Pharm; 2008 Apr 28; 34(4):453-8. PubMed ID: 18401788
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
    Nagaich U, Gulati N.
    Drug Deliv Transl Res; 2016 Jun 28; 6(3):289-98. PubMed ID: 27072979
    [Abstract] [Full Text] [Related]

  • 12. Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability.
    Han S, Shen JQ, Gan Y, Geng HM, Zhang XX, Zhu CL, Gan L.
    Acta Pharmacol Sin; 2010 Aug 28; 31(8):990-8. PubMed ID: 20686524
    [Abstract] [Full Text] [Related]

  • 13. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
    Khurana S, Jain NK, Bedi PM.
    Life Sci; 2013 Nov 13; 93(21):763-72. PubMed ID: 24113071
    [Abstract] [Full Text] [Related]

  • 14. Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC).
    Doktorovová S, Araújo J, Garcia ML, Rakovský E, Souto EB.
    Colloids Surf B Biointerfaces; 2010 Feb 01; 75(2):538-42. PubMed ID: 19879736
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Development of artemether-loaded nanostructured lipid carrier (NLC) formulation for topical application.
    Nnamani PO, Hansen S, Windbergs M, Lehr CM.
    Int J Pharm; 2014 Dec 30; 477(1-2):208-17. PubMed ID: 25290810
    [Abstract] [Full Text] [Related]

  • 17. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers.
    Abdel-Mottaleb MM, Neumann D, Lamprecht A.
    Eur J Pharm Biopharm; 2011 Sep 30; 79(1):36-42. PubMed ID: 21558002
    [Abstract] [Full Text] [Related]

  • 18. Development of ibuprofen-loaded nanostructured lipid carrier-based gels: characterization and investigation of in vitro and in vivo penetration through the skin.
    Sütő B, Berkó S, Kozma G, Kukovecz Á, Budai-Szűcs M, Erős G, Kemény L, Sztojkov-Ivanov A, Gáspár R, Csányi E.
    Int J Nanomedicine; 2016 Sep 30; 11():1201-12. PubMed ID: 27099487
    [Abstract] [Full Text] [Related]

  • 19. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C, Almeida A, Sousa J, Lamarche I, Gobin P, Marchand S, Couet W, Olivier JC, Pais A.
    Eur J Pharm Biopharm; 2014 Feb 30; 86(2):133-44. PubMed ID: 24333401
    [Abstract] [Full Text] [Related]

  • 20. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers.
    Baek JS, Pham CV, Myung CS, Cho CW.
    Int J Pharm; 2015 Nov 30; 495(2):701-9. PubMed ID: 26423175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.